Chief Scientific Officer Of Adaptive Biotechnologies Trades $505.90 Thousand In Company Stock
Harlan Robins, Chief Scientific Officer at Adaptive Biotechnologies (NASDAQ:ADPT), made a large buy and sell of company shares on September 15, according to a new SEC filing.